Search results

In our February 3rd blog, we discussed the difference between genetics and genomics. Today, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.

Issue 35 of The Altascientist covers the benefits of high potency drugs, and the considerations for safe, efficient, and regulatory-compliant manufacturing.

Explore Canada's advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.

This Q&A with Dr. Norbert Makori and Pierre Jolicoeur reveals insights on preclinical gene therapy studies and capabilities at Altasciences’ site in Seattle

Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.